Metastatic Prostate Cancer Market is Projected to Witness Significant Growth by 2036 Owing to the Launch of Novel Therapies and Expanding Treatment Landscape | DelveInsight

Source Summary

The metastatic prostate cancer market is anticipated to witness substantial growth through 2036, driven by the increasing prevalence of prostate cancer, advancements in diagnostic capabilities, expanding use of androgen receptor pathway inhibitors, and the emergence of innovative targeted therapies. The